Research snapshot · Not reviewed

ICLRICON

Full-service CRO, FSP model

WATCH

Conviction●○○○○1 of 5

Research target—Snapshot target

Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed

Market cap13.26BSnapshot value

The thesis

Full-service CRO with strong FSP model. Balanced client mix between large pharma (stable) and biotech (growth). Global delivery footprint.

Catalysts

FSP model growth (sponsors building multi-vendor portfolios); biotech funding recovery; global trial footprint expansion; BIOSECURE tailwind.

What breaks it

Funding-cycle beta; pricing pressure in FSP model; client concentration risk; Ireland-domiciled (trades NASDAQ — clean access).

Social sentiment

needs X/Reddit sentiment sweep

Snapshot · Not reviewed

Smart money

🟢 Confirmed · 13F 20+/5- · short↓0.15

Snapshot · Not reviewed